Resolve Biosciences Risk Report
Explore Resolve Biosciences across six non‑financial risk dimensions:ESG, Workforce, News & Media, Cybersecurity, Legal & Regulatory, Operational. Unlock the full report, original sources and timelines, and enable continuous monitoring.
Summary
🛡️ Financial & Liquidity
Resolve Biosciences has actively pursued financial growth, securing significant investments to expand its operations. A critical event involved the company securing $71 million in a Series B financing, highlighting confidence from investors and a robust financial position. This influx of funds likely bolstered their liquidity, enabling further expansion of their Molecular Cartography technology.
- Resolve Biosciences secured $71 million in a Series B financing round 🗓 2022-10-24.
📜 Innovation & R&D
The company has consistently been at the forefront of innovation in the biotechnology sector, particularly in spatial biology and gene expression analysis. The launch of their Molecular Cartography™ workflow set new standards for single-cell spatial analysis, emphasizing their leadership in this niche. Continued efforts in R&D reflect their commitment to maintaining and advancing their technological edge.
- Resolve Biosciences announced the launch of a fully automated Molecular Cartography™ workflow, setting a new standard for single-cell spatial analysis 🗓 2022-06-07.
- The company showcases the versatility and data quality of their Molecular Cartography at an industry conference 🗓 2023-01-09.
- Resolve Biosciences expands its Meridian Molecular Cartography™ service program, catering to various species and tissue types 🗓 2023-02-06.
🏅 Awards & Recognition
Resolve Biosciences has earned industry acknowledgment for its advancements and stature as a leading force in spatial biology. The company’s recognition among the top 10 spatial biology companies accentuates its reputation and influence within the biotechnology research domain.
- Recognized in the top 10 spatial biology companies 🗓 2023-11-08.
- Again featured in the top 10 spatial biology companies list 🗓 2024-10-30.
Profile
News & Media
Real‑time aggregation of trusted sources tracking company‑related events with sentiment and topic tags for rapid risk triage.
Sign up to unlock Resolve Biosciences’s complete news feed with sentiment and topic tags.
View Full ReportEntity List
Continuous third‑party screening across global sanctions, enforcement, and watchlist sources with unified entity resolution and real‑time alerts.
| Name | Issuer | Status |
|---|---|---|
| ACF List of War Enablers | Anti-Corruption Foundation | |
| African Development Bank Debarred Entities | African Development Bank Group | |
| Argentina Members of Parliament | Honorable Cámara de Diputados de la Nación Argentina | |
| Argentina RePET Sanctions | Ministerio de Justicia | |
| Armenia Public Officials and Associates | Hetq Online | |
| Asian Development Bank Sanctions | Asian Development Bank | |
| Australian Sanctions Consolidated List | Department of Foreign Affairs and Trade | |
| Democratic People's Republic Of Korea (North Korea) Sanctions Regime | Department of Foreign Affairs and Trade | |
| Former Federal Republic Of Yugoslavia Sanctions Regime | Department of Foreign Affairs and Trade | |
| Iran Sanctions Regime | Department of Foreign Affairs and Trade |
Sign up to unlock Resolve Biosciences’s sanctions, enforcement, and watchlist risk profile.
View Full ReportESG
Verification of declared ESG commitments and certifications with evidence links, score signals, and status updates across E, S, and G.
| Name | Status |
|---|---|
| Sustainable Finance Disclosure Regulation | |
| Global Reporting Initiative Standards | |
| EU Taxonomy Regulation | |
| EU Corporate Sustainability Reporting Directive | |
| California Transparency in Supply Chains Act | |
| EU Non-Financial Reporting Directive | |
| ISO 14001 | |
| Sustainability Accounting Standards Board Standards | |
| Task Force on Climate-related Financial Disclosures | |
| UN Guiding Principles on Business and Human Rights |
Sign up to unlock Resolve Biosciences’s ESG commitments, certifications, and controversy signals.
View Full ReportCybersecurity
Verification of adherence to recognized security standards, mapping control coverage and gaps affecting third‑party and supply‑chain risk.
| Certification | Status |
|---|---|
| General Data Protection Regulation | |
| Digital Operational Resilience Act | |
| Cybersecurity Maturity Model Certification | |
| NIST Cybersecurity Framework | |
| NIST 800-53 Revision 5 | |
| California Consumer Privacy Act | |
| ISO/IEC 27001 | |
| Health Insurance Portability and Accountability Act | |
| Payment Card Industry Data Security Standard | |
| Federal Information Security Modernization Act |
Sign up to unlock Resolve Biosciences’s security standards, control gaps, and exposure risks.
View Full ReportGet Resolve Biosciences's full Non-Financial Risk Report
By signing up, you agree to our Terms and Privacy Policy.